Drug Shortage Report for QUININE - ODAN
Report ID | 153195 |
Drug Identification Number | 00695459 |
Brand name | QUININE - ODAN |
Common or Proper name | Quinine Sulfate Capsules |
Company Name | ODAN LABORATORIES LTD |
Market Status | MARKETED |
Active Ingredient(s) | QUININE SULFATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | P01BC |
ATC description | ANTIMALARIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-01-17 |
Estimated end date | 2022-12-30 |
Actual end date | 2022-12-30 |
Shortage status | Resolved |
Updated date | 2023-01-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2023-01-11 | French | Compare |
v13 | 2023-01-11 | English | Compare |
v12 | 2022-10-05 | French | Compare |
v11 | 2022-10-05 | English | Compare |
v10 | 2022-07-19 | French | Compare |
v9 | 2022-07-19 | English | Compare |
v8 | 2022-06-07 | French | Compare |
v7 | 2022-06-07 | English | Compare |
v6 | 2022-06-07 | French | Compare |
v5 | 2022-06-07 | English | Compare |
v4 | 2022-03-14 | French | Compare |
v3 | 2022-03-14 | English | Compare |
v2 | 2022-01-20 | French | Compare |
v1 | 2022-01-20 | English | Compare |
Showing 1 to 14 of 14